Ingrid Moen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ingrid Moen has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Anders Karlson
RISE Borås Sweden
1 shared publication- Balázs Gergely Madas
Environmental Physics Department, Institute for Energy Security and Environmental Safety, HUN-REN Centre for Energy Research, Budapest, Hungary
1 shared publication - Camilla Haglerød
Oxy Solutions AS, Oslo, Norway
1 shared publication Cecilie Brekke Rygh
Department of Biomedicine University of Bergen Bergen Norway
1 shared publication- Christoph A. Schatz
Bayer AG, Pharmaceuticals Berlin Germany
1 shared publication Eva Sjöström
RISE Stockholm Sweden
1 shared publication
Latest Publications
- Open Access
- 1 July 2025
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 53 (1) , 633-646
Biodistribution of free Francium-221 and Bismuth-213 in Tumour-bearing SCID mice after successful development of Actinium-225/Francium-221 radionuclide generator Set-up
Purpose: Despite the clinical evidence of actinium-225 ( 225 Ac)-based targeted alpha therapies (TαT) efficacy, optimized treatment regimens are needed to improve overall clinical response rates and decrease toxicities. The nuclear recoil effect of 225 Ac and its resulting daughter nuclides have been hypothesized to contribute to non-targeted damage. However, a lack of generator concepts for radionuclidically pure francium-221 ( 221 Fr), involvement of strong acids for elution, and its short half-life (4.8 min), has limited in vivo studies. Here, we report on a successful application of an 225 Ac/ 221 Fr generator concept and the in vivo distribution of 221 Fr and bismuth-213 ( 213 Bi). Methods: The immobilization of 225 Ac and elution of 221 Fr was performed on a LN2 resin column. The biodistribution of 221 Fr and 213 Bi was investigated in male SCID mice with LNCaP tumors at 5 and 15 min p.i. Results: Our results indicate that LN2 resin is a highly efficient resin for selective separation of 225 Ac and 221 Fr. The use of 0.1 M NaOAc enabled continuous elution at a constant pH. The biodistribution study revealed a fast distribution of 221 Fr and 213 Bi already 5 min p.i. We observed a strong accumulation of 221 Fr to the kidneys, salivary glands and small intestine. In 213 Bi-injected mice, the highest accumulation was in kidney and liver. Conclusion: We present an unprecedented concept utilizing LN2 resin in 225 Ac/ 221 Fr generator applications. Successfully eluted and injected 221 Fr fractions showed strong accumulation of 221 Fr and 213 Bi in key organs. Our data provide preliminary evidence of the potential contribution of recoiled progeny radionuclides to side-effects in non-targeted organs.
- 1 July 2025
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 53 (1) , 633-646
Open AccessBiodistribution of free Francium-221 and Bismuth-213 in Tumour-bearing SCID mice after successful development of Actinium-225/Francium-221 radionuclide generator Set-up
Purpose: Despite the clinical evidence of actinium-225 ( 225 Ac)-based targeted alpha therapies (TαT) efficacy, optimized treatment regimens are needed to improve overall clinical response rates and decrease toxicities. The nuclear recoil effect of 225 Ac and its resulting daughter nuclides have been hypothesized to contribute to non-targeted damage. However, a lack of generator concepts for radionuclidically pure francium-221 ( 221 Fr), involvement of strong acids for elution, and its short half-life (4.8 min), has limited in vivo studies. Here, we report on a successful application of an 225 Ac/ 221 Fr generator concept and the in vivo distribution of 221 Fr and bismuth-213 ( 213 Bi). Methods: The immobilization of 225 Ac and elution of 221 Fr was performed on a LN2 resin column. The biodistribution of 221 Fr and 213 Bi was investigated in male SCID mice with LNCaP tumors at 5 and 15 min p.i. Results: Our results indicate that LN2 resin is a highly efficient resin for selective separation of 225 Ac and 221 Fr. The use of 0.1 M NaOAc enabled continuous elution at a constant pH. The biodistribution study revealed a fast distribution of 221 Fr and 213 Bi already 5 min p.i. We observed a strong accumulation of 221 Fr to the kidneys, salivary glands and small intestine. In 213 Bi-injected mice, the highest accumulation was in kidney and liver. Conclusion: We present an unprecedented concept utilizing LN2 resin in 225 Ac/ 221 Fr generator applications. Successfully eluted and injected 221 Fr fractions showed strong accumulation of 221 Fr and 213 Bi in key organs. Our data provide preliminary evidence of the potential contribution of recoiled progeny radionuclides to side-effects in non-targeted organs.
- Open Access
- 13 June 2018
- Published by Wiley in Health Science Reports
- Vol. 1 (7) , e57
Development of a novel in situ gelling skin dressing: Delivering high levels of dissolved oxygen at pH 5.5.
Background and aims: Wound healing requires appropriate oxygen and pH levels. Oxygen therapy and pH‐modulating treatments have shown positive effects on wound healing. Thus, a dressing, which combines high levels of dissolved oxygen (DO) with the pH of intact skin, may improve wound healing. Our aims were to (1) formulate an in situ gelling dressing with high levels of DO and with the pH level of intact skin, (2) evaluate physical and chemical properties of the dressing, and (3) elucidate basic effects of elevated levels of DO on human skin cells in vitro.Methods: A dressing was formulated with 15 to 16 wt% poloxamer 407, acetate buffer, and oxygenated water. Stability of pH and DO, rheology, and shelf life were analysed. Furthermore, in vitro studies of the effect of increased levels of DO were performed.Results: An in situ gelling wound dressing, with a DO concentration ranging between 25 and 35 mg/L and a pH of 5.5, was formulated. The DO concentration was stable above 22 mg/L for at least 30 hours when applied on a surface at 35°C and covered for directed diffusion into the intended wound area. At storage, the dressing had stable pH for 3 months and stable DO concentration over 30 mg/L for 7 weeks. Increasing DO significantly enhanced intracellular ATP in human skin cells, without changing reactive oxygen species production, proliferation rate, or viability.Conclusion: The developed dressing may facilitate wound healing by delivering controlled and stable oxygen levels, providing adjustable pH for optimized healing, and increasing intracellular ATP availability.
- 13 June 2018
- Published by Wiley in Health Science Reports
- Vol. 1 (7) , e57
Open AccessDevelopment of a novel in situ gelling skin dressing: Delivering high levels of dissolved oxygen at pH 5.5.
Background and aims: Wound healing requires appropriate oxygen and pH levels. Oxygen therapy and pH‐modulating treatments have shown positive effects on wound healing. Thus, a dressing, which combines high levels of dissolved oxygen (DO) with the pH of intact skin, may improve wound healing. Our aims were to (1) formulate an in situ gelling dressing with high levels of DO and with the pH level of intact skin, (2) evaluate physical and chemical properties of the dressing, and (3) elucidate basic effects of elevated levels of DO on human skin cells in vitro.Methods: A dressing was formulated with 15 to 16 wt% poloxamer 407, acetate buffer, and oxygenated water. Stability of pH and DO, rheology, and shelf life were analysed. Furthermore, in vitro studies of the effect of increased levels of DO were performed.Results: An in situ gelling wound dressing, with a DO concentration ranging between 25 and 35 mg/L and a pH of 5.5, was formulated. The DO concentration was stable above 22 mg/L for at least 30 hours when applied on a surface at 35°C and covered for directed diffusion into the intended wound area. At storage, the dressing had stable pH for 3 months and stable DO concentration over 30 mg/L for 7 weeks. Increasing DO significantly enhanced intracellular ATP in human skin cells, without changing reactive oxygen species production, proliferation rate, or viability.Conclusion: The developed dressing may facilitate wound healing by delivering controlled and stable oxygen levels, providing adjustable pH for optimized healing, and increasing intracellular ATP availability.
- Open Access
- 1 March 2008
- Published by Wiley in The FASEB Journal
- Vol. 22 (S1) , 926.3-926
Mouse muscle and skin permeability coefficients (Ps) to macromolecular contrast agent using magnetic resonance imaging (MRI)
We evaluated the use of MRI to measure blood to tissue clearances of Gadomer (kindly provided by Bayer Schering Pharma), a gadolinium based contrast agent with an apparent MW of 35 kDa. C57 black mice (25–30 g) were anaesthetized (Isoflurane) and Gadomer was injected i.v. during scanning using a 7T Bruker Pharmascan. A T1‐weighted dynamic sequence (TR/TE= 11.1/2.5 ms, flip angle= 25°, time resolution 0.8 s, frames = 500) was used to measure signal intensity over time in selected Regions of Interest (ROI's) in the masseter muscle and head skin. Tracer concentration in blood vessels was also measured in small ROI's placed over arteries. Controlled bolus injection of 0.1 mmol Gd/kg BW caused an initial “step” increase in tracer intensity as the vascular volume was filled. Subsequent blood to tissue tracer exchange resulted in further (initially linear) increased (slope) in tracer intensity over periods of 100–300 seconds. Ps to Gadomer in tissue ROI's was calculated from the slope and step, assuming a microvessel volume to surface ratio of 2.5 microns (Curry et al, AJP245:H496, 1983). Average Ps values (X10‐7 cm/sec) were 2.9 ±1.0 (muscle) and 15±5 (skin). Corrections for the fall in plasma concentration increased estimates by 10–20%. The method enables repeated measurements Ps in organs of individual mouse of periods of days to weeks. Our research is supported by Research Council of Norway and University of Bergen.
- 1 March 2008
- Published by Wiley in The FASEB Journal
- Vol. 22 (S1) , 926.3-926
Open AccessMouse muscle and skin permeability coefficients (Ps) to macromolecular contrast agent using magnetic resonance imaging (MRI)
We evaluated the use of MRI to measure blood to tissue clearances of Gadomer (kindly provided by Bayer Schering Pharma), a gadolinium based contrast agent with an apparent MW of 35 kDa. C57 black mice (25–30 g) were anaesthetized (Isoflurane) and Gadomer was injected i.v. during scanning using a 7T Bruker Pharmascan. A T1‐weighted dynamic sequence (TR/TE= 11.1/2.5 ms, flip angle= 25°, time resolution 0.8 s, frames = 500) was used to measure signal intensity over time in selected Regions of Interest (ROI's) in the masseter muscle and head skin. Tracer concentration in blood vessels was also measured in small ROI's placed over arteries. Controlled bolus injection of 0.1 mmol Gd/kg BW caused an initial “step” increase in tracer intensity as the vascular volume was filled. Subsequent blood to tissue tracer exchange resulted in further (initially linear) increased (slope) in tracer intensity over periods of 100–300 seconds. Ps to Gadomer in tissue ROI's was calculated from the slope and step, assuming a microvessel volume to surface ratio of 2.5 microns (Curry et al, AJP245:H496, 1983). Average Ps values (X10‐7 cm/sec) were 2.9 ±1.0 (muscle) and 15±5 (skin). Corrections for the fall in plasma concentration increased estimates by 10–20%. The method enables repeated measurements Ps in organs of individual mouse of periods of days to weeks. Our research is supported by Research Council of Norway and University of Bergen.